Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication December 7, 2021
- Revision received January 20, 2022
- Published online June 1, 2022.
Article Versions
- previous version (January 27, 2022 - 13:16).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2022 by the Society of Nuclear Medicine and Molecular Imaging.
Author Information
Statistics from Altmetric.com
Cited By...
Article usage
In this issue
Jump to section
Related Articles
Cited By...
- Challenges with 177Lu-PSMA-617 Radiopharmaceutical Therapy in Clinical Practice
- Survey of Clinical Protocols for the Use of 177Lu-PSMA-617 in the United States
- Real-World Experience with 177Lu-PSMA-617 Radioligand Therapy After Food and Drug Administration Approval
- SNMMI Consensus Statement on Patient Selection and Appropriate Use of 177Lu-PSMA-617 Radionuclide Therapy
- A VISION Substudy of Reader Agreement on 68Ga-PSMA-11 PET/CT Scan Interpretation to Determine Patient Eligibility for 177Lu-PSMA-617 Radioligand Therapy
- SNMMI Consensus Statement on Patient Selection and Appropriate Use of 177Lu-PSMA-617 Radionuclide Therapy
- A VISION Substudy of Reader Agreement on 68Ga-PSMA-11 PET/CT Scan Interpretation to Determine Patient Eligibility for 177Lu-PSMA-617 Radioligand Therapy
- A VISION Substudy of Reader Agreement on 68Ga-PSMA-11 PET/CT Scan Interpretation to Determine Patient Eligibility for 177Lu-PSMA-617 Radioligand Therapy
- Is 18F-FDG PET Needed to Assess 177Lu-PSMA Therapy Eligibility? A VISION-like, Single-Center Analysis
- Clinical Trials of Prostate-Specific Membrane Antigen Radiopharmaceutical Therapy
- Eligibility for 177Lu-PSMA Therapy Depends on the Choice of Companion Diagnostic Tracer: A Comparison of 68Ga-PSMA-11 and 99mTc-MIP-1404 in Metastatic Castration-Resistant Prostate Cancer
- Reply: What Does an Imaging "Selection" Claim Actually Mean?
- What Does an Imaging "Selection" Claim Actually Mean?